The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical CRO Treatment Market Research Report 2024
Synopsis
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
The global Preclinical CRO Treatment market was valued at US$ 714.3 million in 2023 and is anticipated to reach US$ 1612.8 million by 2030, witnessing a CAGR of 12.2% during the forecast period 2024-2030.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
This report aims to provide a comprehensive presentation of the global market for Preclinical CRO Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO Treatment.
Report Scope
The Preclinical CRO Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical CRO Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical CRO Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Preclinical contract research organizations (CROs) offer research and development services to pharmaceutical and biotechnology companies during the early stages of drug development, including preclinical studies and animal testing.
The global Preclinical CRO Treatment market was valued at US$ 714.3 million in 2023 and is anticipated to reach US$ 1612.8 million by 2030, witnessing a CAGR of 12.2% during the forecast period 2024-2030.
The market for preclinical CRO services is driven by the demand for specialized expertise and resources in drug development and the need for efficient and cost-effective preclinical research. The market's growth is also influenced by the increasing outsourcing of preclinical studies by pharmaceutical and biotech companies.
This report aims to provide a comprehensive presentation of the global market for Preclinical CRO Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical CRO Treatment.
Report Scope
The Preclinical CRO Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical CRO Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical CRO Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Laboratory Corporation of America
Envigo
Eurofins Scientific
PRA Health Science
Wuxi Apptec Co.,Ltd.
Medpace
Pharmaceutical Product Development
Paraxel
Pharmaron
Joinn Laboratories
Medicilon Inc.
Crown Bioscience
Yinuosi Bio-Technology
Segment by Type
Bioanalysis and DMPK Studies
Toxicology Testing
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preclinical CRO Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bioanalysis and DMPK Studies
1.2.3 Toxicology Testing
1.3 Market by Application
1.3.1 Global Preclinical CRO Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Medical Device Companies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preclinical CRO Treatment Market Perspective (2019-2030)
2.2 Preclinical CRO Treatment Growth Trends by Region
2.2.1 Global Preclinical CRO Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preclinical CRO Treatment Historic Market Size by Region (2019-2024)
2.2.3 Preclinical CRO Treatment Forecasted Market Size by Region (2025-2030)
2.3 Preclinical CRO Treatment Market Dynamics
2.3.1 Preclinical CRO Treatment Industry Trends
2.3.2 Preclinical CRO Treatment Market Drivers
2.3.3 Preclinical CRO Treatment Market Challenges
2.3.4 Preclinical CRO Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preclinical CRO Treatment Players by Revenue
3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2019-2024)
3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical CRO Treatment Revenue
3.4 Global Preclinical CRO Treatment Market Concentration Ratio
3.4.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2023
3.5 Preclinical CRO Treatment Key Players Head office and Area Served
3.6 Key Players Preclinical CRO Treatment Product Solution and Service
3.7 Date of Enter into Preclinical CRO Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Treatment Breakdown Data by Type
4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2019-2024)
4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2025-2030)
5 Preclinical CRO Treatment Breakdown Data by Application
5.1 Global Preclinical CRO Treatment Historic Market Size by Application (2019-2024)
5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preclinical CRO Treatment Market Size (2019-2030)
6.2 North America Preclinical CRO Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preclinical CRO Treatment Market Size by Country (2019-2024)
6.4 North America Preclinical CRO Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preclinical CRO Treatment Market Size (2019-2030)
7.2 Europe Preclinical CRO Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preclinical CRO Treatment Market Size by Country (2019-2024)
7.4 Europe Preclinical CRO Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preclinical CRO Treatment Market Size (2019-2030)
8.2 Asia-Pacific Preclinical CRO Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Preclinical CRO Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preclinical CRO Treatment Market Size (2019-2030)
9.2 Latin America Preclinical CRO Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preclinical CRO Treatment Market Size by Country (2019-2024)
9.4 Latin America Preclinical CRO Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preclinical CRO Treatment Market Size (2019-2030)
10.2 Middle East & Africa Preclinical CRO Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Preclinical CRO Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction
11.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Laboratory Corporation of America
11.2.1 Laboratory Corporation of America Company Detail
11.2.2 Laboratory Corporation of America Business Overview
11.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction
11.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2019-2024)
11.2.5 Laboratory Corporation of America Recent Development
11.3 Envigo
11.3.1 Envigo Company Detail
11.3.2 Envigo Business Overview
11.3.3 Envigo Preclinical CRO Treatment Introduction
11.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2019-2024)
11.3.5 Envigo Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 PRA Health Science
11.5.1 PRA Health Science Company Detail
11.5.2 PRA Health Science Business Overview
11.5.3 PRA Health Science Preclinical CRO Treatment Introduction
11.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2019-2024)
11.5.5 PRA Health Science Recent Development
11.6 Wuxi Apptec Co.,Ltd.
11.6.1 Wuxi Apptec Co.,Ltd. Company Detail
11.6.2 Wuxi Apptec Co.,Ltd. Business Overview
11.6.3 Wuxi Apptec Co.,Ltd. Preclinical CRO Treatment Introduction
11.6.4 Wuxi Apptec Co.,Ltd. Revenue in Preclinical CRO Treatment Business (2019-2024)
11.6.5 Wuxi Apptec Co.,Ltd. Recent Development
11.7 Medpace
11.7.1 Medpace Company Detail
11.7.2 Medpace Business Overview
11.7.3 Medpace Preclinical CRO Treatment Introduction
11.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2019-2024)
11.7.5 Medpace Recent Development
11.8 Pharmaceutical Product Development
11.8.1 Pharmaceutical Product Development Company Detail
11.8.2 Pharmaceutical Product Development Business Overview
11.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction
11.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2019-2024)
11.8.5 Pharmaceutical Product Development Recent Development
11.9 Paraxel
11.9.1 Paraxel Company Detail
11.9.2 Paraxel Business Overview
11.9.3 Paraxel Preclinical CRO Treatment Introduction
11.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2019-2024)
11.9.5 Paraxel Recent Development
11.10 Pharmaron
11.10.1 Pharmaron Company Detail
11.10.2 Pharmaron Business Overview
11.10.3 Pharmaron Preclinical CRO Treatment Introduction
11.10.4 Pharmaron Revenue in Preclinical CRO Treatment Business (2019-2024)
11.10.5 Pharmaron Recent Development
11.11 Joinn Laboratories
11.11.1 Joinn Laboratories Company Detail
11.11.2 Joinn Laboratories Business Overview
11.11.3 Joinn Laboratories Preclinical CRO Treatment Introduction
11.11.4 Joinn Laboratories Revenue in Preclinical CRO Treatment Business (2019-2024)
11.11.5 Joinn Laboratories Recent Development
11.12 Medicilon Inc.
11.12.1 Medicilon Inc. Company Detail
11.12.2 Medicilon Inc. Business Overview
11.12.3 Medicilon Inc. Preclinical CRO Treatment Introduction
11.12.4 Medicilon Inc. Revenue in Preclinical CRO Treatment Business (2019-2024)
11.12.5 Medicilon Inc. Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Detail
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Preclinical CRO Treatment Introduction
11.13.4 Crown Bioscience Revenue in Preclinical CRO Treatment Business (2019-2024)
11.13.5 Crown Bioscience Recent Development
11.14 Yinuosi Bio-Technology
11.14.1 Yinuosi Bio-Technology Company Detail
11.14.2 Yinuosi Bio-Technology Business Overview
11.14.3 Yinuosi Bio-Technology Preclinical CRO Treatment Introduction
11.14.4 Yinuosi Bio-Technology Revenue in Preclinical CRO Treatment Business (2019-2024)
11.14.5 Yinuosi Bio-Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
